News

Filter by year:

Filter by tags:

5/02/2022

GTP Abstracts Accepted for Presentation at the 25th Annual Meeting of The American Society of Gene & Cell Therapy

Twelve abstracts from the Gene Therapy Program at the University of Pennsylvania were accepted for presentation at the The American Society of Gene & Cell Therapy (ASGCT)'s 25th Annual Meeting, held May 16th-19th 2022 in Washington, D.C. Congratulations to all GTP presenters and their teams!

4/05/2022

40 Under 40: Meet the second group of honorees in the class of 2022

The Philadelphia Business Journal honored Christina Furia, MS, in its 2022 class of 40 Under 40! Christina is Senior Associate Director of External Manufacturing at GTP. This honor recognizes dynamic business leaders for their achievements and contributions to their companies and the region.

1/18/2022

GTP and The Center for Breakthrough Medicines Partner in the Manufacturing of Gene Therapies

The University of Pennsylvania's Gene Therapy Program (GTP) and The Center for Breakthrough Medicines (CBM) have signed a landmark collaboration agreement to combine Penn's knowledge and expertise in the development of gene therapies with CBM's manufacturing capacity and singular focus on advanced therapies.

12/08/2021

GTP Announces Expansion of R&D Partnership with Passage Bio

GTP announced the continued expansion of its R&D partnership with Passage Bio, a Penn spinout focused on developing transformative therapies for central nervous system disorders. Passage Bio exercised two additional options with GTP, which focused on CNS diseases with high unmet need.

12/07/2021

GTP Expands Collaboration with Scout Bio Via Next-Generation Vector Technologies

The Gene Therapy Porgram (GTP) at the University of Pennsylvania announced an expanded collaboration agreement with Penn spinout, Scout Bio. The agreement will grant Scout Bio exclusive rights, in the field of animal health, to an emerging viral vector capsid technology for use in animal gene therapy, as well as extended option terms to other next-generation AAV vector technologies.

11/17/2021

Dr. Jim Wilson Named one of the Top 20 Translational Researchers of 2020.

Dr. Jim Wilson, Director of the Gene Therapy Program (GTP) at the University of Pennsylvania, has been recognized by Nature Biotechnology as one of the Top 20 Translational Researchers of 2020.